Trial Profile
Bridging Care to HCV Treatment Among Opiate Dependent Patients on Buprenorphine/Naloxone Maintenance Therapy: A Pilot Study of Treating HCV With Epclusa at a Psychiatrist-staffed Outpatient Addiction Clinic
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 02 Oct 2020 Status changed from active, no longer recruiting to completed.
- 13 Jul 2020 Planned End Date changed from 1 May 2020 to 1 Sep 2020.
- 01 Apr 2020 Planned End Date changed from 1 Mar 2020 to 1 May 2020.